论文部分内容阅读
目的探究病毒性肝炎合并胆囊炎的临床治疗措施及疗效。方法将2013年3月份到2014年9月份之间院内收治的96例病毒性肝炎合并胆囊炎的患者用来作为病情研究对象,并事先得到患者的同意,随机分成对照组和研究组2个小组,每个小组分别48名患者。对照组给予常规的护肝和抗病毒治疗,研究组在护肝以及抗病毒治疗的基础上给予抗生素治疗,两周后比较两组患者的临床疗效。结果治疗两周后两组患者的临床治疗总有效率,并无显著性差异,且研究组和对照组患者的凝血功能、血清肝功能指标等方面无显著差异。结论对于病毒性肝炎合并胆囊炎的临床治疗,抗生素并不能够起到显著的效果,还是需要结合患者的实际情况进行对症治疗。
Objective To investigate the clinical treatment and efficacy of viral hepatitis complicated with cholecystitis. Methods Ninety-six patients with viral hepatitis complicated with cholecystitis treated in the hospital between March 2013 and September 2014 were enrolled in the study. Their consent was obtained beforehand and divided into two groups: control group and study group , Each team was 48 patients. The control group was given conventional liver protection and antiviral therapy. The study group was given antibiotics on the basis of liver protection and antiviral therapy. Two weeks later, the clinical efficacy of the two groups was compared. Results After two weeks of treatment, the total effective rate of clinical treatment between the two groups showed no significant difference. There was no significant difference in the coagulation function and serum liver function between the study group and the control group. Conclusion For the clinical treatment of viral hepatitis complicated with cholecystitis, antibiotics can not play a significant effect, or need to be combined with the actual situation of patients symptomatic treatment.